Display Settings:

Format

Send to:

Choose Destination

    Antimicrob Agents Chemother. 2007 Jun;51(6):2208-10. Epub 2007 Apr 9.

    Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants.

    Zorrilla CD, Van Dyke R, Bardeguez A, Acosta EP, Smith B, Hughes MD, Huang S, Watts DH, Heckman B, Jiménez E, McSherry G, Mofenson L.

    Obstetrics and Gynecology Department, UPR School of Medicine, P.O. Box 365067, San Juan, Puerto Rico. czorrilla@rcm.upr.edu

    Saquinavir boosted with low-dose ritonavir given with zidovudine and lamivudine was well tolerated by pregnant women and their infants. All mothers had <400 human immunodeficiency virus type 1 RNA copies/ml at delivery. Two had elevated liver transaminases and amylase. Seven infant adverse events were possibly treatment related (anemia, neutropenia, and hyperbilirubinemia).

    PMID: 17420209 [PubMed - indexed for MEDLINE]

    PMCID: 1891372

    Supplemental Content

    Click here to read Click here to read Click here to read Click here to read Click here to read

    Patient drug information